Bp Plc maintained its stake in Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 32,000 shares of the health services provider’s stock at the end of the second quarter. Bp Plc’s holdings in Cigna Corporation were worth $5,354,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Advisor Partners LLC increased its stake in Cigna Corporation by 3.6% in the second quarter. Advisor Partners LLC now owns 5,635 shares of the health services provider’s stock worth $943,000 after buying an additional 195 shares during the last quarter. Algert Global LLC increased its stake in Cigna Corporation by 49.9% in the second quarter. Algert Global LLC now owns 12,993 shares of the health services provider’s stock worth $2,175,000 after buying an additional 4,328 shares during the last quarter. Pictet Asset Management Ltd. increased its stake in Cigna Corporation by 2.7% in the second quarter. Pictet Asset Management Ltd. now owns 354,675 shares of the health services provider’s stock worth $57,184,000 after buying an additional 9,443 shares during the last quarter. TD Asset Management Inc. increased its stake in Cigna Corporation by 12.5% in the second quarter. TD Asset Management Inc. now owns 289,718 shares of the health services provider’s stock worth $48,496,000 after buying an additional 32,270 shares during the last quarter. Finally, Cullen Frost Bankers Inc. increased its stake in Cigna Corporation by 0.5% in the second quarter. Cullen Frost Bankers Inc. now owns 71,720 shares of the health services provider’s stock worth $12,006,000 after buying an additional 335 shares during the last quarter. Institutional investors and hedge funds own 86.91% of the company’s stock.

Cigna Corporation (NYSE:CI) opened at 175.63 on Wednesday. The firm has a 50-day moving average of $171.37 and a 200-day moving average of $158.04. The stock has a market capitalization of $44.96 billion, a PE ratio of 23.45 and a beta of 0.46. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.50.

Cigna Corporation (NYSE:CI) last announced its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping the consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.40%. The business’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.98 EPS. On average, equities analysts expect that Cigna Corporation will post $10.00 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/08/09/bp-plc-has-5354000-position-in-cigna-corporation-nyseci.html.

A number of analysts have recently commented on the company. Royal Bank Of Canada restated a “buy” rating and set a $185.00 price objective on shares of Cigna Corporation in a report on Wednesday. Zacks Investment Research downgraded Cigna Corporation from a “buy” rating to a “hold” rating in a report on Tuesday. Citigroup Inc. upped their price objective on Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a report on Monday. Morgan Stanley increased their price target on Cigna Corporation from $184.00 to $188.00 and gave the company an “overweight” rating in a report on Monday. Finally, Deutsche Bank AG increased their price target on Cigna Corporation from $180.00 to $190.00 and gave the company a “buy” rating in a report on Monday. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. Cigna Corporation presently has a consensus rating of “Buy” and a consensus target price of $180.06.

In other news, EVP Nicole S. Jones sold 20,312 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $160.04, for a total transaction of $3,250,732.48. Following the transaction, the executive vice president now owns 44,737 shares in the company, valued at approximately $7,159,709.48. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Lisa R. Bacus sold 11,455 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $161.57, for a total transaction of $1,850,784.35. Following the transaction, the executive vice president now owns 24,753 shares in the company, valued at approximately $3,999,342.21. The disclosure for this sale can be found here. Insiders sold a total of 219,558 shares of company stock worth $37,135,665 in the last quarter. Insiders own 1.30% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.